Medical Cannabis and Cannabinoids

SNDL Inc. (NASDAQ: SNDL, CSE: SNDL) (“SNDL” or the “Company”) announces the completion of the acquisition of certain assets of Surterra Holdings, Inc. and certain of its affiliates (collectively, “Parallel”), a U.S. vertically integrated cannabis operator with state-licensed operations in Florida, Texas and Massachusetts (the “Parallel Transaction”). The operating assets acquired from Parallel include 56 […]

Vireo Growth Inc. (CSE: VREO) (OTCQX: VREOF) (“Vireo”), a leading vertically integrated cannabis company and agricultural markets platform, and Planet 13 Holdings Inc. (CSE: PLTH) (OTCQX: PLNH) (“Planet 13”), a leading vertically integrated multi-state cannabis company, announce that they have entered into a definitive merger agreement (the “Merger Agreement”) pursuant to which Vireo will, as

Vireo Growth Inc. (CSE: VREO) (OTCQX: VREOD) (“Vireo” or the “Company”), announces the closing of its previously announced acquisition to acquire an indirect 49% equity interest in HA-MD, LLC (“HA-MD”), the sole owner of Chesapeake Integrated Health Institute, LLC and Maryland Alternative Relief, LLC, pursuant to a membership interest purchase agreement dated November 3, 2025

Curaleaf Holdings, Inc (TSX: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading international provider of consumer products in cannabis, has completed the buyout of the remaining 45% stake not previously owned in Four 20 Pharma GmbH, a fully EU-GMP and GDP licensed German producer and distributor of medical cannabis. Four 20 Pharma is recognized